Document:

EX-10.14

 Exhibit 10.14 

Execution Version 

DIRECTOR NOMINATION AGREEMENT 

THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of October 28, 2022 (the
“Effective Time”), by and among SeaStar Medical Holding Corporation, a Delaware corporation (f/k/a LMF Acquisition Opportunities, Inc.) (the “Company”) and LMFAO Sponsor, LLC, a Florida limited
liability company (the “Sponsor”). Capitalized terms used but not otherwise defined in this Agreement have the respective meanings given to them in the Merger Agreement (as defined below). 

WHEREAS, the Company and certain of its affiliates have consummated the merger and other transactions (collectively, the
“Transactions”) contemplated by the Agreement and Plan of Merger, dated as of April 21, 2022, by and among the Company, LMF Merger Sub, Inc., a Delaware corporation and SeaStar Medical, Inc., a Delaware corporation; 

WHEREAS, in its capacity as the sponsor of the special purpose acquisition company that was the predecessor to the Company, the Sponsor
desires that, after giving effect to the Transactions, it will continue to have representation on the Board so as to continue to create value for its direct and indirect equityholders (collectively with the Sponsor, the “LMF
Parties”) and for the other direct and indirect equityholders of the Company; and 
 WHEREAS, in furtherance of the foregoing,
the Sponsor desires to have certain director nomination rights with respect to the Company, and the Company desires to provide the Sponsor, on behalf of the LMF Parties, with such rights, in each case, on the terms and conditions set forth herein.

 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficient of which are hereby acknowledged, each of the parties to this Agreement agrees as follows: 
 ARTICLE 1 

NOMINATION RIGHT 

Section 1.01. Board Nomination Right. 

(a) From the Effective Time until the termination of this Agreement in accordance with Section 2.01, at every
meeting of the board of directors of the Company (the “Board”), or a committee thereof, or action by written consent, at or by which directors of the Company are appointed by the Board or are nominated to stand for election
and elected by the stockholders of the Company, the Sponsor shall have the right to appoint or nominate for election to the Board, as applicable, two (2) individuals, to serve as directors of the Company (any individual appointed or nominated
by the Sponsor for election to the Board pursuant to this Section 1.01(a) and such two individuals shall be Bruce M. Rodgers and Richard Russell (a “Nominee” and, collectively, the
“Nominees”)). The Sponsor shall have the right to appoint or nominate another individual other than the Bruce M. Rodgers and Richard Russell pursuant to this Agreement only if the Board, by a majority vote, approves such
appointment or nomination, and upon such approval, such individual shall be deemed a “Nominee” under this Agreement. 

 (b) The Company shall take all necessary actions within its control, including, but not
limited to, calling a meeting of the Board or executing an action by unanimous written consent of the Board, such that, as of the Effective Time, the Nominees shall either be elected by the Company’s stockholders at the meeting held to approve
the Transactions or appointed to the Board as of the Effective Time, in each case, as Class II directors (as defined in the Company’s Organizational Documents, each a “Class II
Director”). 
 (c) From and after the Effective Time, the Company shall take all actions necessary (including, without
limitation, calling special meetings of the Board and the stockholders of the Company and recommending, supporting and soliciting proxies) (“Necessary Action”) to ensure that: (i) the applicable Nominees are included in the
Board’s slate of nominees to the stockholders of the Company for each election of Class II Directors and recommended by the Board at any meeting of stockholders called for the purpose of electing Class II Directors; and (ii) each
applicable Nominee up for election is included in the proxy statement prepared by management of the Company in connection with the Company’s solicitation of proxies or consents in favor of the foregoing for every meeting of the stockholders of
the Company called with respect to the election of Class II Directors, and at every adjournment or postponement thereof, and on every action or approval by written consent of the stockholders of the Company or the Board with respect to the
election of Class II Directors. 
 (d) If any Nominee ceases to serve for any reason, the Sponsor shall, subject to the Sponsor then
being entitled to nominate an individual for election or appointment as a director pursuant to Section 1.01(a), be entitled to designate for election or appointment as a director such person’s successor in accordance
with this Agreement and the Company shall take all Necessary Action to cause any such vacancy to be filled by such replacement director designated by the Sponsor as promptly as practicable after such designation (and in any event prior to the next
meeting or action of the Board). 
 (e) Notwithstanding any of this Section 1.01 to the contrary, the election or
appointment of any Nominee to the Board shall be subject to the prior execution by such Nominee of an irrevocable resignation letter in the form attached hereto as Exhibit A. 

(f) The Company shall indemnify the Nominees who are appointed or elected as Class II Directors on the same basis as all other members of
the Board and pursuant to indemnity agreements with terms that are no less favorable to such Nominees than the indemnity agreements entered into between the Company and its other non-employee directors. 

(g) Nominees who are appointed or elected as Class II Directors shall be entitled to compensation (including equity awards) and the
reimbursement of expenses that is consistent with the compensation received and the expenses reimbursed by other non-employee directors of the Company. 

(h) Notwithstanding the provisions of this Section 1.01, the Sponsor shall not be entitled to designate a Person as
a nominee to the Board upon a written determination by the Nominating and Corporate Governance Committee of the Company (which determination shall set forth in writing reasonable grounds for the determination) that the Person would not be qualified
under any applicable law, rule or regulation to serve as a director of the Company. In such an event, subject to the last sentence of Section 1(a), the Sponsor shall be entitled to select a Person as a replacement Nominee and the Company shall
use its best efforts to cause that Person to be nominated as a Nominee at the same meeting (or, if permitted, pursuant to the same action by written consent of the stockholders) as the initial Person was to be nominated. 

  
 2 

 ARTICLE 2 

MISCELLANEOUS 

Section 2.01. Termination. This Agreement shall terminate automatically and become void and of no further force or effect, without
any notice or other action by any Person, as of the date immediately following the meeting of stockholders of the Company where Class II directors are elected and that takes place after the Effective Time. 

Section 2.02. Notices. All notices, requests and other communications to either party hereunder shall be in writing (including
electronic transmission) and shall be given in accordance with the provisions of the Merger Agreement. 
 Section 2.03.
Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in
full force and effect so long as the economic or legal substance of the transactions contemplated by this Agreement is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid,
illegal or incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in a mutually acceptable manner in order that the
Transactions contemplated by this Agreement be consummated as originally contemplated to the fullest extent possible. 
 Section 2.04.
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither this Agreement nor any of
the rights, interests or obligations hereunder shall be assigned, directly or indirectly (including by operation of law), by any party without the prior written consent of the other parties. Notwithstanding any of the foregoing, the Sponsor may
assign its rights and obligations hereunder, without the prior consent of the other parties, to (i) an Affiliate transferee, in connection with a transfer by the Sponsor of shares of the Company’s Common Stock to one of the Sponsor’s
Affiliates or (ii) Bruce M. Rodgers, Richard Russell or any of their respective designees. 
 Section 2.05. No Third Party
Beneficiaries. This Agreement is exclusively for the benefit of the parties hereto, and their respective successors and permitted assigns, and this Agreement shall not be deemed to confer upon or give to any other third party any remedy, claim,
liability, reimbursement, cause of action or other right by virtue of any applicable law in any jurisdiction to enforce any of the terms of this Agreement. 

Section 2.06. Entire Agreement. This Agreement constitutes the entire agreement among the parties hereto with respect to the
subject matter of this Agreement and supersedes all other prior agreements and understandings, both written and oral, between the parties hereto with respect to the subject matter of this Agreement. Each party acknowledges and agrees that, in
entering into this Agreement, such party has not relied on any promises or assurances, written or oral, that are not reflected in this Agreement. 

  
 3 

 Section 2.07. Governing Law. This Agreement, and all claims or causes of action
based upon, arising out of, or related to this Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to principles or rules of conflict of
Laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. 
 Section 2.08.
Jurisdiction; WAIVER OF TRIAL BY JURY. Any Action based upon, arising out of or related to this Agreement or the transactions contemplated hereby may be brought in federal and state courts located in the State of Delaware, and each of the
parties hereto irrevocably submits to the exclusive jurisdiction of each such court in any such Action, waives any objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect
of the Action shall be heard and determined only in any such court, and agrees not to bring any Action arising out of or relating to this Agreement or the transactions contemplated hereby in any other court. Nothing herein contained shall be deemed
to affect the right of any party to serve process in any manner permitted by Law or to commence legal proceedings or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments obtained in any Action
brought pursuant to this Section 2.08. EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE SUBJECT MATTER HEREOF.

 Section 2.09. Specific Performance. The parties hereto acknowledge that the rights of each party to consummate the
transactions contemplated hereby are unique and recognize and affirm that in the event of a breach of this Agreement by any party, money damages may be inadequate and the non-breaching party may have no
adequate remedy at law. Accordingly, the parties hereto agree that such non-breaching party shall have the right to enforce its rights and the other party’s obligations hereunder by an action or actions
for specific performance and/or injunctive relief (without posting of bond or other security), including any order, injunction or decree sought by such non-breaching party to cause the other party to perform
its/their respective agreements and covenants contained in this Agreement and to cure breaches of this Agreement, without the necessity of proving actual harm and/or damages or posting a bond or other security therefore. Each party further agrees
that the only permitted objection that it may raise in response to any action for any such equitable relief is that it contests the existence of a breach or threatened breach of this Agreement. 

Section 2.10. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but
all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or e-mail shall be as effective as delivery of a
manually executed counterpart of the Agreement. 

  
 4 

 Section 2.11. Amendment. This Agreement may be amended, modified or supplemented
at any time only by the written consent of all of the parties hereto, and any amendment, modification or supplement so effected shall be binding on all of the parties. 

Section 2.12. Rights Cumulative. Except as otherwise expressly limited by this Agreement, all rights and remedies of each of the
parties under this Agreement will be cumulative, and the exercise of one or more rights or remedies will not preclude the exercise of any other right or remedy available under this Agreement or law. 

Section 2.13. Further Assurances. Each of the parties hereto shall execute and deliver such further instruments and do such
further acts and things as may be required to carry out the intent and purpose of this Agreement. 
 Section 2.14. Enforcement.
Each of the parties hereto covenants and agrees that the disinterested members of the Board have the right to enforce, waive or take any other action with respect to this Agreement on behalf of the Company. 

Section 2.15. Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. 
 [Signature Page Follows] 

  
 5 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first written above. 
  

			
	SEASTAR MEDICAL HOLDING CORPORATION
		
	By:	 	 /s/ Eric Schlorff

	Name:	 	Eric Schlorff
	Title:	 	Chief Executive Officer
	
	LMFAO SPONSOR, LLC
		
	By:	 	 /s/ Bruce M. Rodgers

	Name:	 	Bruce M. Rodgers
	Title:	 	President and Chief Executive Officer

 [Signature Page to Director Nomination Agreement] 

 Exhibit A 

FORM OF IRREVOCABLE RESIGNATION 
 [__],
20[__] 
 SeaStar Medical Holding Corporation 
 3513 Brighton
Blvd., Suite 410 
 Denver, CO 80216 
 Attn: Eric Schlorff 

Re: Resignation 
 Ladies and Gentlemen: 

This irrevocable resignation is delivered pursuant to Section 1.01(e) of the Director Nomination Agreement, dated as of [•],
2022 (the “Agreement”), by and between SeaStar Medical Holding Corporation (the “Company”) and the Sponsor (as defined in the Agreement). If, following such time that the Agreement is terminated in
accordance with its terms, the Board (as such term is defined in the Agreement) requests in writing that I resign as a director of the Company, I hereby tender the immediate resignation of my position as a director of the Company and from any and
all committees of the Board on which I serve. 
 This resignation may not be withdrawn by me at any time. 

 

	
	Sincerely,
	
	  

	[Applicable Nominee]EX-10.15

 Exhibit 10.15 

FIRST AMENDMENT TO CREDIT AGREEMENT 

THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) dated October 28, 2022 is entered into by and between SEASTAR
MEDICAL, INC., a Delaware corporation (the “Borrower”), and LM FUNDING AMERICA, INC. (the “Lender”). 

RECITALS 
 WHEREAS, the
Borrower is currently indebted to the Lender pursuant to the terms and conditions of that certain Credit Agreement dated as of September 9, 2022, as amended from time to time (the “Credit Agreement”); and 

WHEREAS, the Lender and the Borrower have agreed to certain changes in the terms and conditions set forth in the Credit Agreement and have
agreed to amend the Credit Agreement to reflect said changes. 
 NOW, THEREFORE, for valuable consideration, the receipt and sufficiency off
which are hereby acknowledged, the parties hereto agree that the Credit Agreement shall be amended as follows: 
 1. Amendment to Exhibit
1. The definition of “Maturity Date” in Exhibit 1 is hereby amended and restated in its entirety to read as follows: 

“Maturity Date” means the date that is the first (1st) anniversary of the
closing of the merger of LMF Merger Sub, Inc., a Delaware corporation (“Merger Sub”), with and into Borrower, pursuant to that certain Agreement and Plan of Merger, dated as of April 21, 2022, by and among LMF Acquisition
Opportunities, Inc., a Delaware corporation, Merger Sub, and Borrower (the “Merger Agreement”), or if earlier, the termination of the Merger Agreement. 

2. Amendment to Section 2.2. Section 2.2 of the Credit Agreement is hereby amended and restated in its entirety
to read as follows: 
 “2.2. Note. The Loan shall be evidenced by a Promissory Note in the face amount of the Maximum
Loan Amount (as amended or modified from time to time, the “Note”) and shall be payable in accordance with the terms of the Note and this Agreement.” 

3. Deletion of Exhibit 2. Exhibit 2 (Form of Note) is hereby deleted in its entirety. 

4. Effective Date. The Borrower shall, on the date hereof, execute and deliver to Lender the Security Agreement and Security Documents
in a form acceptable to Lender. The foregoing delivery shall be a condition to the effectiveness of the amendments set forth in Sections 1—3 above. 

 5. Full Force and Effect. Except as specifically provided herein, all terms and
conditions of the Credit Agreement remain in full force and effect, without waiver or modification. All terms defined in the Credit Agreement shall have the same meaning when used in this Amendment. This Amendment and the Credit Agreement shall be
read together, as one document. 
 6. Reaffirmation of Representations, Warranties and Covenants. The Borrower hereby remakes all
representations and warranties contained in the Credit Agreement and reaffirms all covenants set forth therein. The Borrower further certifies that as of the date of this Amendment there exists no Event of Default as defined in the Credit Agreement,
nor any condition, act or event which with the giving of notice or the passage of time or both would constitute any such Event of Default. The Borrower agrees that all references to the “Credit Agreement” in the Note (as defined in the
Credit Agreement and as amended by this Amendment) shall be a reference to the Credit Agreement as amended hereby and as may be further amended from time to time, and the Note is hereby deemed to be amended accordingly. 

7. Counterparts. This Amendment may be executed simultaneously in multiple counterparts, each of which shall be deemed an original, and
it shall not be necessary in making proof of this Amendment to produce or account for more than one such counterpart. 
 8. Continuation
of Prior Agreements. It is the intention of the parties hereto that all Loan Documents previously executed by and between the parties shall remain in full force and effect except to the extent they are inconsistent with this Amendment. This
Amendment and the Credit Agreement shall be read together, as one document. All references to the Credit Agreement in the Loan Documents shall be deemed to refer to the Credit Agreement as amended by this Amendment, as hereafter amended or modified
from time to time. 
 [Signature Page Follows] 

 IN WITNESS WHEREOF, the parties hereto, intending to be legally bound hereby, have caused
this Amendment to be effective as of the effective date set forth above. 
 SEASTAR MEDICAL, INC., a Delaware corporation 

 

			
	By:	 	 /s/ Eric Schlorff

	Name:	 	Eric Schlorff
	Title:	 	Chief Executive Officer

 LM FUNDING AMERICA, INC., Delaware corporation 
  

			
	By:	 	 /s/ Bruce M. Rodgers

	Name:	 	Bruce M. Rodgers
	Title:	 	Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]